Oramed Reports Positive End of Phase 2 Meeting With the FDA for Oral Insulin July 15, 2020 Press Releases
Oramed Announces Positive Initial Clinical Trial Results for Treatment of NASH With Oral Insulin June 15, 2020 Press Releases
Oramed Pharmaceuticals to Present at the 80th American Diabetes Association Scientific Session, to be Held Virtually This Year in June May 5, 2020 Press Releases
Oramed Pharmaceuticals Issues CEO Shareholder Letter Providing Business Update Amid COVID-19 April 1, 2020 Press Releases
Oramed Receives Positive Feedback From End-of-Phase 2 Oral Insulin CMC Meeting With FDA March 19, 2020 Press Releases
Oramed Pharmaceuticals Inc. Prices Public Offering of Common Stock for Aggregate Proceeds of $21 Million February 27, 2020 Press Releases
Oramed Pharmaceuticals Inc. Announces Proposed Public Offering of Common Stock February 26, 2020 Press Releases
Oramed Reports Positive Results in the Final Cohort of Its Phase 2b Oral Insulin Trial February 26, 2020 Press Releases